Form 4 Tracker
Kiniksa Pharmaceuticals International, plc
KNSA

33 insider filings · Latest: Jun 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 1, 2026May 5 8:54 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Sale
58,424$53.71$3.1M65,623(D)

View →

May 1, 2026May 1 8:45 PMPaolini John F.
Proposed Sale
58,424$53.71$3.1M

View →

May 1, 2026May 1 8:32 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
48,565$54.02$2.6M0(D)

View →

Apr 30, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
2,141$54.01$115.6K0(D)

View →

Apr 29, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
22,544$54.01$1.2M0(D)

View →

Apr 28, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
483,654$51.86$25.1M0(D)

View →

Apr 28, 2026Apr 29 8:46 PMBarry D QuartDirector
Sale
13,099$50.10$656.3K12,546(D)

View →

Apr 28, 2026Apr 28 8:49 PMPatel Sanj K
Proposed Sale
344,591$51.60$17.8M

View →

Apr 9, 2026Apr 13 8:35 PMMichael R MegnaCHIEF ACCOUNTING OFFICER
Sale
6,625$46.69$309.3K27,418(D)

View →

Apr 9, 2026Apr 13 8:34 PMRoss MoatCHIEF OPERATING OFFICER
Sale
1,703$46.69$79.5K12,029(D)

View →

Apr 9, 2026Apr 9 8:03 PMMoat Ross
Proposed Sale
1,703$46.69$79.5K

View →

Apr 9, 2026Apr 9 8:02 PMMegna Michael R
Proposed Sale
6,625$46.69$309.3K

View →

Apr 6, 2026Apr 8 8:43 PMSanj K PatelDirector, CHAIRMAN & CEO
Sale
7,278$50.01$364.0K0(D)

View →

Apr 6, 2026Apr 8 8:39 PMRoss MoatCHIEF OPERATING OFFICER
Sale
2,367$48.58$115.0K12,029(D)

View →

Apr 6, 2026Apr 8 8:34 PMBarry D QuartDirector
Sale
6,901$50.00$345.1K12,546(D)

View →

Apr 6, 2026Apr 6 8:55 PMQuart Barry D
Proposed Sale
20,000$50.00$1.0M

View →

Apr 6, 2026Apr 6 8:54 PMPatel Sanj K
Proposed Sale
219,591$50.00$11.0M

View →

Apr 6, 2026Apr 6 8:04 PMMoat Ross
Proposed Sale
2,367$48.58$115.0K

View →

Mar 9, 2026Mar 11 8:38 PMMark RagosaCHIEF FINANCIAL OFFICER
Sale
36,722$45.92$1.7M12,086(D)

View →

Mar 9, 2026Mar 9 9:24 PMRagosa Mark
Proposed Sale
36,722$45.92$1.7M

View →

Page 1 of 5

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 29, 2026Jun 2 8:52 PMBarry D QuartDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:52 PMBarry D QuartDirector
Option Exercise
2,7990(D)

View →

May 29, 2026Jun 2 8:51 PMKimberly J PopovitsDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:51 PMKimberly J PopovitsDirector
Option Exercise
2,7990(D)

View →

Jun 1, 2026Jun 2 8:50 PMSanj K PatelDirector, CHAIRMAN & CEO
Conversion
900,000626,160(I)

View →

May 29, 2026Jun 2 8:48 PMTracey L MccainDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:48 PMTracey L MccainDirector
Option Exercise
2,7990(D)

View →

May 29, 2026Jun 2 8:46 PMThomas MalleyDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:46 PMThomas MalleyDirector
Option Exercise
2,7990(D)

View →

May 29, 2026Jun 2 8:44 PMRichard S LevyDirector
Option Exercise
2,7990(D)

View →

May 29, 2026Jun 2 8:44 PMRichard S LevyDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:42 PMBradley G ColeDirector
Option Exercise
2,7990(D)

View →

May 29, 2026Jun 2 8:42 PMBradley G ColeDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:30 PMBAKER BROS. ADVISORS LPDirector
Grant/Award
72,948$48.3836,474(I)

View →

May 1, 2026May 5 8:54 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Option Exercise
58,424$10.3629,670(D)

View →

May 1, 2026May 1 8:32 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
48,565$30.930(D)

View →

Apr 30, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
2,141$30.9348,565(D)

View →

Apr 29, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
22,544$30.9350,706(D)

View →

Apr 28, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
483,654$30.9373,250(D)

View →

Apr 28, 2026Apr 29 8:46 PMBarry D QuartDirector
Option Exercise
13,099$14.3313,237(D)

View →

Page 1 of 3

Next →